Inactive 8(a) Set-Aside (FAR 19.8)

This is not a Request for Quotes - This is a Request for Information (RFI); information submitted will be used for Market Research Purposes only. The U.S. Food and Drug Administration's (FDA), Office ... This is not a Request for Quotes - This is a Request for Information (RFI); information submitted will be used for Market Research Purposes only. The U.S. Food and Drug Administration's (FDA), Office of Acquisitions and Grants Services (OAGS), is conducting market research to support the acquisition planning for the installation and on-going preventive maintenance, testing, warranty, reporting and documentation of its security equipment. Systems utilized by the Physical Security Office include access control systems (ACS), video imaging systems, closed circuit television (CCTV), various security detection and initiating devices, perimeter detection, and others. Approximately one-third of the agency's employees are stationed outside of the Washington, D. C. area, staffing over 150 field offices and laboratories, including five regional offices and 20 district offices, across the US states and US territories. This RFI is being issued in accordance with Federal Acquisition Regulation Part 10, Market Research. It is for information, planning and market research purposes only and is not to be construed as a commitment by the Government to issue a solicitation or ultimately award a contract. This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. Respondents will not be notified of the results of the review. FDA is seeking information from any qualified 8(a) small business contractor that can perform the services found in the attached draft Statement of Work. Telephone inquiries will not be accepted or acknowledged, and no feedback, discussions, or evaluations will be provided to companies regarding their submissions or information received. The FDA does not intend to make a selection decision or award a contract on the basis of the submitted responses to this RFI. See attached DRAFT Statement of Work (SOW), which is subject to change. Interested parties are highly encouraged to review the attached DRAFT SOW and provide comments and feedback using the Tracked Changes and Comment features found in MS Word, and answer the questions provided on the attached “RFI Vendor Feedback” form. THERE IS NO SOLICITATION AT THIS TIME. This request for information does not constitute a request for quotes; submission of any information in response to this market survey is purely voluntary; the government assumes no financial responsibility for any costs incurred in responding to this notice. Respondents to this notice must provide the following information: A Cover Page that includes the following: Company name and address DUNS Number Point of Contact (Name, Email, and Phone Number) EMAIL SUBJECT: Request for Information - FDA-RFI-1225276 Written responses to all questions found in the attachement titled "RFI Vendor Feedback." Vendors are highly encouraged to submit feedback on the DRAFT SOW using Tracked Changes and Comment features in the documents. All responses must be emailed to the Contract Specialist, Pierre Smith, at pierre.smith@fda.hhs.gov, and the Contracting Officer, James Whitt, at james.whitt@fda.hhs.gov. NO calls will be accepted or answered regarding this notice. Thank you.